Biomenace Remastered overhauls the '90s action platformer with new graphics, improved gameplay, and a fourth chapter set ...

The price band for the Neochem Bio IPO has been set between ₹93 and ₹98 per equity share. The basis of allotment for the Neochem Bio IPO is expected to be finalised on Friday, December 5. Successful ...

Curi Bio’s ribbon cutting in April 2025 for its new headquarters on Seattle’s waterfront. Elliot Fisher, co-founder and chief business officer, cuts the ribbon with a sword while CEO Nicholas Geisse ...

Sanofi says it has reached an agreement with Dren Bio that would see it take control of autoimmune disease treatment DR-0201, a bispecific antibody-based myeloid cell engager with the potential to ...

The challenges facing biotechs amid the ongoing financial fallout have resulted in the winding down of one US biotech, Vor Bio, and job losses at a clutch of other firms. Cambridge, ...

Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. Its lead products candidate is AXN-2510/IMM2510 that is in Phase 1b/2 clinical trial ...

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...

Akebia Therapeutics has struck a deal for Q32 Bio’s deprioritized complement inhibitor ADX-097, paying $7 million upfront for an asset that forms the centerpiece of its new rare kidney disease ...

A couple were left badly burnt after fleeing for their lives when their fireplace exploded, engulfing their home in an "orange fireball". Angela Palit, 59, described how she was blown across the ...

D microscopy shows that the giant bacterium Thiovulum imperiosus squeezes its DNA into peripheral pouches, not a central mass ...

Anthony Joshua is the former two-time unified WBO, IBF, and WBA heavyweight champion. Joshua first held the titles from March 2018 to July 2019. He later reclaimed the three belts with a unanimous ...